Dr. Alan C. Schwartz, MD

Dr. Schwartz practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Schwartz's NPI, 1023183480, was assigned on November 21, 2006. Dr. Schwartz graduated from Universidad Autonoma de Guadalajara in 1981. Dr. Schwartz holds California license A42023.

Dr. Schwartz's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Schwartz's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. Dmand AI also links Dr. Schwartz to 1 physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schwartz practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Schwartz's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Schwartz's licenses on file in 2 states: California and Illinois.

Dmand AI lists acute skin infection, anxiety, arthritis, bronchitis, chronic diabetes, chronic hypertension, chronic kidney disease and heart failure among the conditions Dr. Schwartz treats.

CMS data shows 61 Medicare services from Dr. Schwartz across 1 procedure code in 2024, all of them office visits, for 26 Medicare patients. Medicare paid $3,871 for them. Every service was in an office.

CMS counts 26 Medicare patients who saw Dr. Schwartz in 2024. 73% of them have high blood pressure, and 54% have arthritis. Their average risk score is 1.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schwartz's median patient age at 68, with 42% women.

In 2024, Dr. Schwartz wrote 2,850 Medicare Part D claims for 136 patients. 84% of them were for generic drugs. CMS names the drug for 2,411 of them, across 64 drugs with 11 or more claims each, at $203,111 in total drug cost. In 2023, CMS named 2,487 claims across 63 drugs.

Dr. Schwartz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Schwartz to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Myocardial Infarction and Infarction.

CMS Open Payments shows 22 general payments to Dr. Schwartz from 4 drug and device companies from 2016 to 2024. Travel and lodging make up the largest share, 67% of the total. Novartis Pharmaceuticals Corporation paid the most, $2,545. It also lists 10 research payments totaling $1,385 in 2018.

Dr. Schwartz graduated from Universidad Autonoma de Guadalajara in 1981.

Dr. Schwartz is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.